NASDAQ: OMER       Omeros Corp
Last Price Today's Change   Day's Range   Trading Volume
14.93   +0.05 (0.34%)  14.17 - 15.07  65,791


Avg Volume (4 weeks):443,073
4 Weeks Range:13.61 - 17.21
4 Weeks Price Volatility (%):
52 Weeks Range:8.50 - 20.92
52 Weeks Price Volatility (%):
Average Price Target: 30.00
Price Target Upside/Downside: +15.07


No recent Headlines for this stock.

Business Background

Omeros Corp is a United States based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3875  1835  324  2916 

Top 10 Active Counters
 CETX 2.54+1.593 
 VISL 0.378+0.085 
 DGLY 2.32+1.20 
 AVP 5.60-0.05 
 AESE 4.87+2.42 
 AABA 19.630.00 
 PFE 34.965-3.225 
 TGE 22.39+0.81 
 NCLH 16.825+1.165 
 AKRX 0.09-0.094 
Partners & Brokers